Silver Spring, Md. - The FDA Dermatologic and Ophthalmic AdvisoryCommittee, by an 8-2 vote, on May 23 recommended approval of alefacept,a systemic drug for the treatment of chronic plaque psoriasis.
Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, and Salivary Biomarkers
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients
What Conferences Are You Planning to Attend in Quarter 1 of 2024?
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium
Skin Cancer Detection With AI: How Intelligent Is It?
POLL: Have Your Patients Asked About Cabtreo for Acne?